Cannabis Central: Wednesday Saw Little Volatility In The Pure-Play Pot Stock Portfolio
The munKNEE.com Pure-Play Pot Stock Portfolio consists of the 25 pure-play* cannabis stocks that trade for more than US$1/share and it went UP just 0.8% on Wednesday with 50% of the stocks in the portfolio going DOWN and 50% of the industry categories in which they operate going DOWN as well. The details are as follows:
Major Winners
Only 1 stock advanced by (almost) 5%, namely:
- Canopy (CGC) +4.9%
10 other stocks went up by less than 4.9% and 3 stocks had no change in price.
Major Losers
Only 1 stock declined by 5% or more, namely:
- cbdMD (YCBD) -7.1%
10 other stocks declined by less than 5% in price.
The 25 munKNEE.com Pure-Play Pot Stock Portfolio includes companies doing business in 4 categories based on their primary area of focus in the cannabis industry. The categories are identified below with how they performed given the performance of the stocks in the portfolio that make up each category:
- The Vertically Integrated (i.e. Seed-to-Sale) Category has 21 portfolio participants that grow, process, and sell cannabis and hemp flower and related products and they went UP 1.0%, on average.
- the 7 Canadian Licensed Producer (LPs) portfolio participants (ACB; APHA; CGC; CRON; OGI; ROMJF and TLRY) went UP 2.4%, on average.
- the 12 U.S. Multi-State Operator (MSOs) portfolio participants (ACRGF; AYRSF; CCHWF; CRLBF; CURLF; GTBIF; HRVSF; JUSHF; PLNHF; SHWZ; TCNNF and TRSSF) went UP 0.6%, on average.
- the 2 hemp seed-to-sale MSO portfolio participants (CWBHF and YCBD) went DOWN 3.8%, on average.
- The Extraction Category has 2 portfolio participants (NEPT and VLNCF) focused on the extraction of cannabis compounds and their infusion into consumer products and they went DOWN 1.5%, on average.
- The Consumption Devices Category has only 1 portfolio participant (GNLN) focused on developing and selling personal consumption devices for cannabis consumers such as vape pens and inhalers and it went DOWN 2.6% in price.
- The Biotechnology Category has only 1 portfolio participant (AVCNF) which markets new drugs utilizing cannabinoids (CBD) and it went DOWN 0.8%.
*Please note: The 25 pure-play stocks in the munKNEE.com Pure-Play Pot Stock Portfolio are just that, pure, deriving 100% of their revenue from the sale of recreational and medicinal cannabis and consumption-related products and, as such, it reflects the true health of the marijuana industry in the U.S. and Canada.
Visit munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample more